Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Go back to Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 200.58 +0.87 (0.44%)
Previous Close $199.71    52 Week High $333.65 
Open $198.88    52 Week Low $223.02 
Day High $201.22    P/E 25.68 
Day Low $198.42    EPS $7.81 
Volume 344,935